If Xana performs similar to existing treatments but with less side effects then there could be interest.
Time will tell but unlikely there is an offer to be expected anytime soon.
GLTA
[INTERVIEW] Actinogen Medical reveals XanaCIDD phase 2a trials, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.72M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.0¢ | $76.91K | 3.662M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 6249038 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 953910 | 3 |
View Market Depth
| Last trade - 12.26pm 26/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |